| Serial Number | 86938999 |
| Word Mark | EPINUKIA |
| Filing Date | Monday, March 14, 2016 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, November 17, 2023 |
| Registration Number | 5194180 |
| Registration Date | Tuesday, May 2, 2017 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 14, 2017 |
| Goods and Services | Pharmaceutical preparations and substances for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical preparations and substances for the treatment of Dravet syndrome, hypoxic-ischaemic encephalopathy, Lennox-Gastaut syndrome (LGS), tuberous sclerosis syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15q infantile spasms, and Doose syndrome; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, bone disorders, hypoxic-ischaemic encephalopathy, drug, alcohol and nicotine abuse and inflammatory disorders; pure extracts of medicinal plants and herbs used for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, hypoxic-ischaemic encephalopathy, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders; herb teas for medicinal purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, November 17, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | GW Research Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge CB249BZ GB |
| Party Name | GW Research Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge CB249BZ GB |
| Party Name | GW Research Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge CB249BZ GB |
| Event Date | Event Description |
| Friday, November 17, 2023 | CANCELLED SEC. 8 (6-YR) |
| Monday, May 2, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Wednesday, September 15, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, September 15, 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, September 15, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, September 15, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, July 28, 2021 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Wednesday, November 29, 2017 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, November 29, 2017 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, May 2, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 14, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 14, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 25, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 10, 2017 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, January 4, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 4, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, January 4, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 4, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 4, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, December 22, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 22, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, December 17, 2016 | ASSIGNED TO LIE |
| Sunday, December 4, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, June 24, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, June 24, 2016 | NON-FINAL ACTION E-MAILED |
| Friday, June 24, 2016 | NON-FINAL ACTION WRITTEN |
| Friday, June 24, 2016 | ASSIGNED TO EXAMINER |
| Thursday, March 17, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 17, 2016 | NEW APPLICATION ENTERED |